This Journal CME activity will examine the application of molecular imaging to advance translational research in chronic inflammation.

This activity is targeted at imaging professionals and is intended to provide the latest information on clinical practice and cutting-edge scientific advances in nuclear cardiology and cardiac imaging.

After reading and reflecting upon this article in the Journal Nuclear Cardiology, the learner should be able to:

• Understand how molecular imaging studies have revealed that atherosclerosis is an inflammatory disease using psoriasis as a disease model
• Describe the multi-system effects of chronic inflammation
• Understand how molecular imaging can be combined with cell-based laboratory studies to refine translational studie

The overall goal of this activity is to increase the learners’ competence in the application of nuclear cardiology strategies in clinical practice.

Evaluation Deadlines: AMA PRA Category 1 Credits™, ARRT Category A, and Participation Credits = November 18, 2022
The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.



Physicians: The American Society of Nuclear Cardiology designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education (CE) credit is accepted by both NMTCB and ARRT. This Journal-based activity has been approved for a maximum of 1 ARRT Category A credits for Technologists.

Release Date: November 19, 2021
Expiration Date: November 18, 2022